ID

34985

Beschrijving

A Study to Assess the Safety and Efficacy of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With FGF Aberrant Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02202746

Link

https://clinicaltrials.gov/show/NCT02202746

Trefwoorden

Versies (1)
  1. 06-02-19 06-02-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

6 februari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT02202746

Engels

Eligibility Breast Cancer NCT02202746

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed metastatic breast cancer relapsed or refractory to approved standard available treatment
Beschrijving

BREAST CANCER METASTATIC RECURRENT | Secondary malignant neoplasm of female breast Unresponsive to Standard therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0741681
UMLS CUI [2,1]
C0346993
UMLS CUI [2,2]
C0205269
UMLS CUI [2,3]
C2936643
prior treatment with standard first line therapy in the metastatic setting
Beschrijving

First line treatment Standard Neoplasm Metastasis

Datatype

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C1442989
UMLS CUI [1,3]
C0027627
availability of tumor tissue sufficient for confirmatory testing of fgfr1 and 11q amplification status
Beschrijving

Availability of Tumor tissue sample | FGFR1 Gene Amplification Testing | 11q Amplification Testing

Datatype

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C0475358
UMLS CUI [2,1]
C1517090
UMLS CUI [2,2]
C0039593
UMLS CUI [3,1]
C0796366
UMLS CUI [3,2]
C1521871
UMLS CUI [3,3]
C0039593
demonstrated progression of disease by radiological or clinical assessment (measurable disease according to recist version 1.1 is not required for enrollment)
Beschrijving

Disease Progression | Measurable Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C1513041
estimated life expectancy >6 months
Beschrijving

Life Expectancy

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
current or recent treatment with biologic anticancer therapies
Beschrijving

Cancer treatment biological

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205460
ongoing aes from prior anticancer therapies
Beschrijving

Adverse events Due to Cancer treatment

Datatype

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0920425
active central nervous system (cns) metastases
Beschrijving

CNS metastases

Datatype

boolean

Alias
UMLS CUI [1]
C0686377
clinically significant or uncontrolled hypertension or cardiac disease
Beschrijving

Hypertensive disease Clinical Significance | Uncontrolled hypertension | Heart Disease Clinical Significance | Heart Disease Uncontrolled

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C2826293
UMLS CUI [2]
C1868885
UMLS CUI [3,1]
C0018799
UMLS CUI [3,2]
C2826293
UMLS CUI [4,1]
C0018799
UMLS CUI [4,2]
C0205318
females who are pregnant or breastfeeding
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
for cohort c (biomarker-negative) patients: greater than 3 lines of previous chemotherapy in the metastatic setting
Beschrijving

Chemotherapy Quantity Neoplasm Metastasis

Datatype

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
Terug naar het begin van de pagina

Similar models

Eligibility Breast Cancer NCT02202746

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
BREAST CANCER METASTATIC RECURRENT | Secondary malignant neoplasm of female breast Unresponsive to Standard therapy
Item
histologically or cytologically confirmed metastatic breast cancer relapsed or refractory to approved standard available treatment
boolean
C0741681 (UMLS CUI [1])
C0346993 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C2936643 (UMLS CUI [2,3])
First line treatment Standard Neoplasm Metastasis
Item
prior treatment with standard first line therapy in the metastatic setting
boolean
C1708063 (UMLS CUI [1,1])
C1442989 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Availability of Tumor tissue sample | FGFR1 Gene Amplification Testing | 11q Amplification Testing
Item
availability of tumor tissue sufficient for confirmatory testing of fgfr1 and 11q amplification status
boolean
C0470187 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
C1517090 (UMLS CUI [2,1])
C0039593 (UMLS CUI [2,2])
C0796366 (UMLS CUI [3,1])
C1521871 (UMLS CUI [3,2])
C0039593 (UMLS CUI [3,3])
Disease Progression | Measurable Disease
Item
demonstrated progression of disease by radiological or clinical assessment (measurable disease according to recist version 1.1 is not required for enrollment)
boolean
C0242656 (UMLS CUI [1])
C1513041 (UMLS CUI [2])
Life Expectancy
Item
estimated life expectancy >6 months
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cancer treatment biological
Item
current or recent treatment with biologic anticancer therapies
boolean
C0920425 (UMLS CUI [1,1])
C0205460 (UMLS CUI [1,2])
Adverse events Due to Cancer treatment
Item
ongoing aes from prior anticancer therapies
boolean
C0877248 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,3])
CNS metastases
Item
active central nervous system (cns) metastases
boolean
C0686377 (UMLS CUI [1])
Hypertensive disease Clinical Significance | Uncontrolled hypertension | Heart Disease Clinical Significance | Heart Disease Uncontrolled
Item
clinically significant or uncontrolled hypertension or cardiac disease
boolean
C0020538 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2])
C0018799 (UMLS CUI [3,1])
C2826293 (UMLS CUI [3,2])
C0018799 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
Pregnancy | Breast Feeding
Item
females who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Chemotherapy Quantity Neoplasm Metastasis
Item
for cohort c (biomarker-negative) patients: greater than 3 lines of previous chemotherapy in the metastatic setting
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial